Plexus (NASDAQ:PLXS - Get Free Report) announced its earnings results on Wednesday. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10), Zacks reports. Plexus had a net margin of 2.82% and a return on equity of 9.51%. Plexus updated its Q2 2025 guidance to 1.460-1.610 EPS.
Plexus Stock Up 0.1 %
Shares of PLXS stock traded up $0.17 on Wednesday, hitting $170.49. The company's stock had a trading volume of 273,613 shares, compared to its average volume of 153,134. Plexus has a fifty-two week low of $90.18 and a fifty-two week high of $172.89. The firm's fifty day moving average price is $162.01 and its 200-day moving average price is $141.04. The stock has a market capitalization of $4.62 billion, a price-to-earnings ratio of 42.52 and a beta of 0.91. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.71.
Wall Street Analyst Weigh In
A number of analysts recently commented on PLXS shares. Stifel Nicolaus boosted their target price on shares of Plexus from $136.00 to $150.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. Benchmark boosted their price objective on Plexus from $150.00 to $165.00 and gave the stock a "buy" rating in a report on Monday, October 28th. KeyCorp assumed coverage on shares of Plexus in a report on Tuesday, October 22nd. They issued a "sector weight" rating for the company. StockNews.com upgraded shares of Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Finally, Needham & Company LLC raised their price objective on shares of Plexus from $144.00 to $162.00 and gave the stock a "buy" rating in a research note on Friday, October 25th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Plexus currently has a consensus rating of "Moderate Buy" and a consensus price target of $159.00.
Get Our Latest Analysis on Plexus
Insiders Place Their Bets
In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the sale, the chief executive officer now owns 74,271 shares of the company's stock, valued at $11,615,241.69. This trade represents a 1.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Patrick John Jermain sold 5,045 shares of the firm's stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $143.13, for a total transaction of $722,090.85. Following the transaction, the chief financial officer now directly owns 24,602 shares of the company's stock, valued at $3,521,284.26. This represents a 17.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,091 shares of company stock valued at $5,377,960 over the last 90 days. 1.76% of the stock is currently owned by company insiders.
Plexus Company Profile
(
Get Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.